Text Size
159 studies found for:    "Aplastic anemia"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
2 Completed A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Severe Aplastic Anemia;   Refractory Severe Aplastic Anemia
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine
3 Recruiting Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia;   Very Severe Aplastic Anemia;   Moderate Aplastic Anemia
Intervention: Drug: Eltrombopag
4 Active, not recruiting Cyclophosphamide Plus Cyclosporine in Treatment-na ve Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Severe Aplastic Anemia
Interventions: Drug: Cyclophosphamide;   Drug: Cyclosporine
5 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath(Registered Trademark))
6 Suspended Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alefacept
7 Completed Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
8 Recruiting Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
9 Completed Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
10 Recruiting Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Intravenous bone marrow mesenchymal stem cells infusion
11 Completed Comparing Therapies for the Treatment of Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Hematologic Disease
Interventions: Drug: Antithymocyte globulin & Cyclosporin A;   Drug: Cyclophosphamide & Cyclosporin A
12 Completed
Has Results 		Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Antithymocyte Globulin
13 Completed Stem Cell Factor Medication for Aplastic Anemia
Conditions: Aplastic Anemia;   Pancytopenia
Intervention: Drug: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)
14 Recruiting Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Radiation: Total Body Irradiation (TBI);   Procedure: Bone Marrow Transplant
15 Active, not recruiting Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Sirolimus (Rapamune)
16 Active, not recruiting Combination Therapy of Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Antithymocyte globulin (ATG);   Drug: Cyclosporine;   Drug: Mycophenolate mofetil (MMF)
17 Completed Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
Conditions: Acute Myeloid Leukemia;   Myelodysplasia;   Acute Lymphoblastic Leukemia;   Chronic Lymphocytic Leukemia;   Follicular Lymphoma;   Multiple Myeloma;   NHL;   Myeloproliferative Diseases;   Chronic Myeloid Leukemia;   Renal Cell Carcinoma;   Aplastic Anemia
Intervention:
18 Completed Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclosporine
19 Terminated Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cytoxan;   Drug: Campath;   Radiation: Total Body Irradiation (TBI);   Drug: FK-506;   Drug: Methotrexate;   Procedure: Stem cell infusion
20 Active, not recruiting Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Alemtuzumab (Campath-1H);   Drug: Thymoglobulin (r-ATG);   Drug: Cyclosporine (CsA)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years